Skip to main content
Skip to main content
Go to homepage

Cardiac Clearance After COVID-19 Infection: An Approach for the Pediatric Patient


By Ira Taub, MD , Pediatric Cardiologist, Akron Children's Hospital, Akron, OH


More about Ira Taub, MD, FAAP

Objectives (Educational Content) :

1. Explain how infection with the SARS-COV-2 virus can cause damage to the heart and how this relates to the risk of sudden cardiac death. 2. Recognize the major cardiac complications from COVID-19 infection in children and identify patients who are at highest risk. 3. Identify the limitations of cardiac screening strategies and describe the appropriate cardiac workup for the pediatric patient presenting with: -Asymptomatic or mild COVID-19 -Moderate to severe COVID-19 -Multisystem Inflammatory Syndrome in Children (MIS-C)

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists and nurses

Identified Gap:

An update on the cardiac effects from COVID-19 in children.

Estimated Time to Complete the Educational Activity:

1 hour

Expiration Date for CME Credit:


Method of Physician Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CME credit.


Dr. Taub has indicated that he has no relevant financial interest in any pharmaceutical or medical device company and that this activity was developed independent of commercial interest.

Accreditation Statement:

Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians.

CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity. 


1--COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa FG, Adler Y, De Ferrari GM. Heart. 2020 Aug;106(15):1127-1131. doi: 10.1136/heartjnl-2020-317186. Epub 2020 Jun 4. PMID: 32499236 Review.

2--Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expert Consensus Statement. Phelan D, Kim JH, Elliott MD, Wasfy MM, Cremer P, Johri AM, Emery MS, Sengupta PP, Sharma S, Martinez MW, La Gerche A. JACC Cardiovasc Imaging. 2020 Dec;13(12):2635-2652. doi: 10.1016/j.jcmg.2020.10.005. Epub 2020 Oct 28.

3--Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play. Kim JH, Levine BD, Phelan D, Emery MS, Martinez MW, Chung EH, Thompson PD, Baggish AL. JAMA Cardiol. 2020 Oct 26. doi: 0.1001/jamacardio.2020.5890. Online ahead of print. PMID: 33104154